Aging
Navigate
Back to articleFigure 3(3 of 12)
100%
Figure 3
Figure 3.Validation of the prognostic model. (AD) Distribution of risk scores for MMGs in TCGA-training, TCGA-test, TCGA-total and GEO cohorts, respective. (EH) Scatter plot of the OS for each patient in the TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (IL) Heatmaps of the risk cohort and the five MMGs in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (MP) The Kaplan-Meier curves in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively. (QT) The AUC at 1-, 3-, and 5-year for the prognostic models in TCGA-training, TCGA-test, TCGA-total, and GEO cohorts, respectively.
Figure 3 — Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing | Aging